{
    "nctId": "NCT02440191",
    "briefTitle": "3DCRT vs. IMRT in Early Breast Cancer",
    "officialTitle": "Postoperative Radiotherapy With Intensity-modulated Radiation Therapy (IMRT) Using Simultaneous Integrated Boost Versus 3-dimensional Conformal Radiotherapy (3D-CRT) in Early Breast Cancer: a Prospective Randomized Trial",
    "overallStatus": "UNKNOWN",
    "conditions": "Radiation Toxicity",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 690,
    "primaryOutcomeMeasure": "Disease-free survival",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. histologically confirmed breast cancer after breast-conserving surgery\n2. pT1-2N0\n3. no evidence of distant metastasis\n4. no previous malignancy\n5. patient age, 20 - 80 years\n6. Karnofsky performance score \u2265 70\n7. adequate bone marrow, liver, and renal function (leucocytes \\> 4,000/mm3, hemoglobin \\> 10 g/dL, platelets \\> 100,000/mm3; serum bilirubin \\< 1.5 mg/dL, serum transaminase \\< 2.5 times the upper normal limit; serum creatinine \\< 1.5 mg/dL).\n8. completion of scheduled chemotherapy\n\nExclusion Criteria:\n\n1. carcinoma in situ of breast\n2. distant metastasis\n3. mastectomy\n4. male\n5. both breast cancer",
    "sex": "ALL",
    "minimumAge": "20 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}